Dashboard
Manage Tickers

MTEMMolecular Templates, Inc.

Nasdaq www.thresholdpharm.com


$ 1.68 $ 0.10 (6.56 %)    

Friday, 26-Apr-2024 09:40:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.705
$ 1.68
$ 0.00 x 0
$ 1.72 x 100
$ 1.68 - $ 1.68
$ 1.40 - $ 9.45
69,212
na
7.67M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-19-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-13-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-30-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 07-31-2017 06-30-2017 10-Q
28 05-16-2017 03-31-2017 10-Q
29 03-27-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-01-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 03-10-2016 12-31-2015 10-K
34 11-02-2015 09-30-2015 10-Q
35 07-30-2015 06-30-2015 10-Q
36 04-30-2015 03-31-2015 10-Q
37 03-03-2015 12-31-2014 10-K
38 11-03-2014 09-30-2014 10-Q
39 08-01-2014 06-30-2014 10-Q
40 05-01-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

molecular-templates-inc-files-for-shelf-of-up-to-1101m-shares-of-common-stock-by-selling-stockholders
Molecular Templates Inc Files For Shelf Of...
04/25/2024 20:55:15

molecular-templates-inc-estimates-that-it-will-incur-aggregate-pre-tax-charges-of-01m-in-connection-with-reduction-in-force-effective-april-30-reduction-to-extend-resources-to-allow-co-to-continue-to-support-clinical-studies-for-mt-6402-mt-8421-and-mt-0169
Molecular Templates Inc Estimates That It ...
04/12/2024 20:26:38

- SEC Filing

molecular-templates-inc-says-reduction-in-force-would-reduce-companys-current-workforce-by-30-approved-a-reduction-in-force-expects-that-reduction-in-force-will-be-complete-by-end-of-april-2024
Molecular Templates Inc Says Reduction In ...
04/12/2024 20:25:54

-SEC Filing 

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 20:31:18

whats-going-on-with-molecular-templates-stock
What's Going On With Molecular Templates S...
04/09/2024 16:37:25

Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients...

molecular-templates-shares-are-trading-higher-after-the-company-announced-that-it-will-present-interim-data-from-its-mt-6402-phase-i-study-in-patients-with-pd-l1-solid-tumors-at-the-2024-aacr-annual-meeting
Molecular Templates shares are trading hig...
04/09/2024 12:29:16

molecular-templates-presents-interim-data-from-mt-6402-phase-i-study-in-patients-with-pd-l1-solid-tumors-at-2024-aacr-annual-meeting
Molecular Templates Presents Interim Data ...
04/09/2024 12:27:23

The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

molecular-templates-shares-are-trading-higher-after-the-company-announced-a-95-million-private-placement-offering
Molecular Templates shares are trading hig...
03/28/2024 13:21:56

molecular-templates-announces-95m-private-placement-offering-and-agreement-to-amend-second-tranche-of-july-2023-purchase-agreement
Molecular Templates Announces $9.5M Privat...
03/28/2024 12:11:31

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/25/2024 17:30:58

top-5-health-care-stocks-which-could-rescue-your-portfolio-in-march
Top 5 Health Care Stocks Which Could Rescu...
03/19/2024 12:08:40

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/18/2024 17:31:33

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/18/2024 13:05:55

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/15/2024 21:33:52

molecular-templates-q3-eps-082-beats-139-estimate-sales-573m-beat-246m-estimate
Molecular Templates Q3 EPS $(0.82) Beats $...
11/13/2023 21:46:31

Molecular Templates (NASDAQ:MTEM) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $...

why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Wynn Resorts Shares Are Trading Lower ...
11/10/2023 18:34:32

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

molecular-templates-announces-first-patient-dosed-in-phase-1-trial-evaluating-mt-8421-a-novel-engineered-toxin-body-targeting-ctla-4-in-advanced-solid-tumors
Molecular Templates Announces First Patien...
11/02/2023 21:28:37

Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")))), a clinical-stage biopharmaceutic...

molecular-templates-on-aug-28-received-notification-from-nasdaq-that-co-had-regained-compliance
Molecular Templates On Aug. 28 Received No...
08/31/2023 20:20:26

molecular-templates-announces-1-for-15-reverse-stock-split
Molecular Templates Announces 1-For-15 Rev...
08/11/2023 15:23:06

Molecular Templates, Inc., (NASDAQ:MTEM) (the "Company"), a clinical-stage biopharmaceutical company developing novel t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION